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SUMMARY 
A 35 years old physically healthy individual, being treated far depression with imipramine and electroplexy, 
developed cardiogenic shock which was managed successfully with inotropic support. The case is presented to high-
light a rare and potentially fatal side effect of tricyclic anti-depressants. 
The concentration of orally adminis-
tered tricyclic antidepressants in heart 
muscle is 40-200 times higher than in 
plasma. Hence, tricyclic antidepressants 
have a number of cardiovascular effects of 
clinical significance including palpitations, 
tachycardia, orthostatic hypotension, arr-
hythmias and electrocardiographic abnor-
malities in the form of prolonged PR and 
QT intervals, depressed ST segment and 
flattened T waves. Precipitation of con-
gestive heart failure and sudden death have 
been reported as rare complications 
(Hollister, 1978). Nevertheless, mortality is 
greater than in patients treated with elec-
troconvulsive therapy, especially in elderly 
males not treated with adequate doses 
(Avery and Winokur, 1976). Tricyclic anti-
depressants in low doses have an antiarrhy-
thmic action on the heart, but higher doses 
may become arrhythmogcnic (Vale and 
Meredith, 1984). We report a case who deve-
loped cardiogenic shock following 
imipramine. 
Case Report 
A 35 year old unmarried Sikh male was 
hospitalised with the complaints of weak-
ness, bodyache, feeling of sadness, disin-
terest in work, poor appetite, loss of weight 
and disturbed sleep with early morning 
awakening of gradual onset over the past 3 
months. 
There was past history of depression 
treated with antidepressant drugs and elec-
troconvulsive thearpy (ECT) about one year 
back. He was the youngest of 6 sibs, from a 
low socioeconomic rural family. His father 
was an alcoholic indulging in wife-beating 
frequently. One of his brothers, who had 
been treated for depression in mental hos-
pital, is an alcoholic and abuses cannabis. As 
a child, patient was neglected and un-
happy, physically weak and frequently ill. 
He studied upto class two. He got enrolled 
voluntarily in military and apparently did 
well in his job. 
Physical examination revealed no ab-
normality. Psychiatric evaluation showed 
depressed facies, psychomotor retardation, 
low tone speech, mood of anxiety and depre-
ssion with fleeting suicidal rumination and 
feeling of worthlessness in a clear sen-
sorium. Relevant investigations including 
hacmogram, urine analysis, ECG, X-Ray 
skull and fundoscopy were normal.' 
The patient was diagnosed to have a re-
currence of his depressive illness and was 
treated with Tab. Imipramine hydrochlo-
ride 7.
r> mg/day in divided doses, gradually 
increasing to 150 mg/day, Tab. Chlordiaze-
poxide 30 mg/day in divided doses, along-
with psychotherapy and other supportive 
measures. Due to suicidal rumination he 
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was also given six bi-weekly electro-
convulsive therapies. He responded gra-
dually, depression became less, suicidal 
ideas disappeared, sleep normalised, appe-
tite improved and he gained weight. 
After about 30 days of starting anti-
depressants and 36 hours after his last ECT, 
the patient suddenly complained of weak-
ness and giddiness without pain in chest, 
nausea or vomiting. On examination he was 
afebrile with tachycardia (140/min, regular, 
low volume), tachypnea (resp rate 26/min), 
hypotension (BP 80/60mm of Hg) and cold 
clammy extremities. Systemic examination 
revealed no abnormalities. Electrocar-
diogram, showed normal sinus rhythm, rate 
140/min., generalized low voltage comp-
lexes and staircase ascent of ST segments. 
Over the next few hours he developed fea-
tures of cardiogenic shock with impaired 
mentation, cold periphery, tachycardia, 
persistant hypotension and oligoanuria. 
Serial ECGs did not reveal any changes of 
IHD nor was there any rise of serum trans-
minase levels. Haemogram, urine analysis, 
liver function tests, blood sugar, blood urea, 
serum creatinine and serum electrolytes 
were all within normal limits. 
He was managed with inotropic support 
with dopamine drip and was required to be 
maintained on the same for six days before 
his cardiovascular status stabilized, urine 
output was restored and ECG had norma-
lised. 
Discussion 
The therapeutic dose of imipramine is 
100-300 mg/day in divided doses. Our pati-
ent was recievingl50 mg/day in divided 
doses, administered under direct supervi-
sion of nursing staff, and so accidental/-
deliberate ingestion of excessive medication 
was ruled out. Pre-existing underlying is-
chemic heart disease and arrhythmias were 
adequately ruled out. The clinical profile, 
serial ECGs and laboratory parameters also 
did not suggest any cardiac illness. 
Therefore, the possibility of myocardial 
failure due to direct depressant effect of 
tricyclic antidepressant a rare cause was 
considered likely. Concurrent admini-
stration of ECT increases the intracellular 
levels of imipramine which may result in 
quinidine like myocardial depression. The 
chances of such depressive action of imipra-
mine on heart increases with increasing 
number of ECTs. But in our patient the 
myocardial failure occured about 36 hours 
after the last ECT. Therefore, the car-
diogenic shock is unlikely to be due to the 
combined effect of ECT and imipramine. 
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